Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
On Target Laboratories LLC has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are split between 2 distinct examiners and distinct art units, suggesting that the company's patent applications are being reviewed across different specialized groups at the USPTO. This distribution across multiple art units may indicate a broader technical scope for the company's current pharmaceutical research and development efforts.
AEDER, SEAN E is the busiest examiner for this portfolio, currently handling 1 pending office action. Since the busiest examiner is responsible for a portion of the total pending actions, the workload is distributed among the distinct examiners. This distribution requires a prosecution approach that accounts for the different perspectives and requirements of multiple examiners and art units. Practitioners must manage separate prosecution tracks, each influenced by the unique tendencies of the examiners involved in these pending actions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHLIENTZ, LEAH H | 1 | 41.9% | +38.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16998587 | TARGETED FLUORESCENT MARKERS IN COMBINATION WITH A FLEXIBLE PROBE | SCHLIENTZ, LEAH H | 162d overdue |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 16998587 | TARGETED FLUORESCENT MARKERS IN COMBINATION WITH A FLEXIBLE PROBE | SCHLIENTZ, LEAH H | 1618 | §103 | Final Rejection | 162d overdue | Pending | Aug 20, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial